Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03359993
Other study ID # CHRD0417
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 1, 2016
Est. completion date September 1, 2019

Study information

Verified date January 2021
Source Centre Hospitalier René Dubos
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators describe a simple and efficient method to give a premedication in the delivery room, using the umbilical vein, directly punctured through Wharton's jelly.


Description:

The umbilical vein is punctured to inject drugs efficiently. The access is simple, the umbilical vein is clearly visible, and a blood reflux can be found easily. The investigators used the same equipment required for a peripheral venous injection: 24 gauge cannula, antisepsis, compress, and a syringe with the prepared anesthetic drugs. The investigators report 5 cases of intubations in the delivery room using this method to administer the premedication.


Recruitment information / eligibility

Status Completed
Enrollment 5
Est. completion date September 1, 2019
Est. primary completion date September 1, 2019
Accepts healthy volunteers
Gender All
Age group N/A to 30 Minutes
Eligibility Inclusion Criteria: - All the patients were preterm neonates intubated in the delivery room for infant respiratory distress syndrome (IRDS). Exclusion Criteria: - Refusal of legal owners

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Premedication of intubation
The umbilical vein is punctured to inject drugs efficiently. The access is simple, the umbilical vein is clearly visible, and a blood reflux can be found easily. We used the same equipment required for a peripheral venous injection: 24 gauge cannula, antisepsis, compress, and a syringe with the prepared anesthetic drugs. We report 5 cases of intubations in the delivery room using this method to administer the premedication.

Locations

Country Name City State
France Centre Hospitalier René Dubos Pontoise

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier René Dubos

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Conditions of intubation Classified from bad to excellent, depending on the neonates' residual tone, vocal chords mobility, and persistence of movements while inserting the tube. Seven months
Secondary Duration of intubation The investigators measure the time in seconds between insertion of the tube and the end of fixation. Seven months
See also
  Status Clinical Trial Phase
Completed NCT03650478 - Assessment of NeuroBOX and NeuroPAP in Infants. N/A
Completed NCT02962505 - Continuous Regional Analysis Device for Neonate Lung
Completed NCT03163108 - Closed-loop Automatic Oxygen Control (CLAC-4) in Preterm Infants N/A
Completed NCT01861795 - Observational Study in Preterm Neonates Who Are Sufficiently Stable on Non-Invasive Ventilatory Support N/A
Completed NCT00296231 - Nasal High Frequency Ventilation in Preterm Infants: A Pilot Study Phase 1